Monday, June 13, 2016

UPDATE 1-Revance to stop developing crow's feet drug after trial failure

June 13 (Reuters) - Revance Therapeutics Inc said

it would discontinue the development of its drug to treat crow's

feet after the topical gel failed a late-stage study.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)